Verrica Pharmaceuticals (VRCA) PT Lowered to $25 at Cowen Following CRL
Tweet Send to a Friend
Cowen analyst Ken Cacciatore lowered the price target on Verrica Pharmaceuticals (NASDAQ: VRCA) to $25.00 (from $35.00) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
